Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part of cells that contain the instructions which tell cells how to make the right proteins to grow and work. Genes are composed of DNA letters that spell out these instructions. Genomic profiling helps investigators understand why the disease develops and the instructions that led to its development. Understanding the genetic factors of the disease can also help investigator understand why the disease of some people can respond to certain therapies differently than others. The genomic profiling will be performed using bone marrow and blood samples that either have already been obtained during a previous clinical procedure or will be obtained at the time of a scheduled clinical procedure. Studying the genetic information in the cells of these samples will provide information about the origin, progression, and treatment of leukemia and myeloproliferative syndromes and myelodysplastic syndrome. Storing the bone marrow and blood samples will allow for additional research and genomic assessments to be performed in the future.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek: od urodzenia do 30 lat
- •Diagnoza białaczki (świeżo rozpoznana lub nawrotowa)
- •Diagnoza zespołu mielodysplastycznego lub mieloproliferatywnego
- •Potwierdzenie diagnozy badaniem histologicznym
- •Dostępna próbka szpiku kostnego lub krwi do badań genetycznych
✗ Disqualifies
- •Niewystarczająca ilość próbki do badań genetycznych
- •Brak planowanego badania szpiku kostnego w ramach leczenia
- •Mniej niż 20% nienormalnych komórek białych w krwi
- •Brak planowanego pobrania krwi
Simplified criteria — AI translation
Trial details
- Maximum age
- 30 Years
- Last updated (source)
- July 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (8)
Connecticut Children's Medical Center
Hartford, United States
Maine Medical Center
Portland, United States
Boston Children's Hospital
Boston, United States
Dana Farber Cancer Institute
Boston, United States
Dartmouth-Hitchcock
Lebanon, United States
Albany Medical Center
Albany, United States
Lifespan Cancer Institute
Providence, United States
University of Vermont Medical Center
Burlington, United States
Trial contact
Yana Pikman, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/17/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.